2628 related articles for article (PubMed ID: 7905616)
1. PC-10 immunostaining of proliferating cell nuclear antigen in posterior uveal melanoma. Enucleation versus enucleation postirradiation groups.
Pe'er J; Gnessin H; Shargal Y; Livni N
Ophthalmology; 1994 Jan; 101(1):56-62. PubMed ID: 7905616
[TBL] [Abstract][Full Text] [Related]
2. Cell proliferation activity in posterior uveal melanoma after Ru-106 brachytherapy: an EORTC ocular oncology group study.
Pe'er J; Stefani FH; Seregard S; Kivela T; Lommatzsch P; Prause JU; Sobottka B; Damato B; Chowers I
Br J Ophthalmol; 2001 Oct; 85(10):1208-12. PubMed ID: 11567966
[TBL] [Abstract][Full Text] [Related]
3. Ki-67 immunostaining in uveal melanoma. The effect of pre-enucleation radiotherapy.
Mooy CM; de Jong PT; Van der Kwast TH; Mulder PG; Jager MJ; Ruiter DJ
Ophthalmology; 1990 Oct; 97(10):1275-80. PubMed ID: 2243677
[TBL] [Abstract][Full Text] [Related]
4. PC-10 as a predictor of prognosis after antigen retrieval in posterior uveal melanoma.
Seregard S; Oskarsson M; Spångberg B
Invest Ophthalmol Vis Sci; 1996 Jun; 37(7):1451-8. PubMed ID: 8641848
[TBL] [Abstract][Full Text] [Related]
5. Tumour cell proliferation after failed ruthenium plaque radiotherapy for posterior uveal melanoma.
Seregard S; Lundell G; Lax I; af Trampe E; Kock E
Acta Ophthalmol Scand; 1997 Apr; 75(2):148-54. PubMed ID: 9197561
[TBL] [Abstract][Full Text] [Related]
6. Enucleation after plaque radiotherapy for posterior uveal melanoma. Histopathologic findings.
Shields CL; Shields JA; Karlsson U; Menduke H; Brady LW
Ophthalmology; 1990 Dec; 97(12):1665-70. PubMed ID: 2087297
[TBL] [Abstract][Full Text] [Related]
7. Infiltrating macrophages in extratumoural tissues after brachytherapy of uveal melanoma.
Toivonen P; Kivelä T
Acta Ophthalmol; 2012 Jun; 90(4):341-9. PubMed ID: 20809904
[TBL] [Abstract][Full Text] [Related]
8. Altered expression of Rb and p53 in uveal melanomas following plaque radiotherapy.
Brantley MA; Worley L; Harbour JW
Am J Ophthalmol; 2002 Feb; 133(2):242-8. PubMed ID: 11812429
[TBL] [Abstract][Full Text] [Related]
9. Effects of proton beam irradiation on uveal melanomas: a comparative study of Ki-67 expression in irradiated versus non-irradiated melanomas.
Chiquet C; Grange JD; Ayzac L; Chauvel P; Patricot LM; Devouassoux-Shisheboran M
Br J Ophthalmol; 2000 Jan; 84(1):98-102. PubMed ID: 10611107
[TBL] [Abstract][Full Text] [Related]
10. The effect of pre-enucleation radiotherapy on mitotic activity of choroidal and ciliary body melanomas.
Augsburger JJ; Eagle RC; Chiu M; Shields JA
Ophthalmology; 1987 Dec; 94(12):1627-30. PubMed ID: 3431833
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical expression of phospho-Akt in uveal melanoma.
Saraiva VS; Caissie AL; Segal L; Edelstein C; Burnier MN
Melanoma Res; 2005 Aug; 15(4):245-50. PubMed ID: 16034301
[TBL] [Abstract][Full Text] [Related]
12. p53 expression in uveal malignant melanomas.
Jay V; Yi Q; Hunter WS; Zielenska M
Pathology; 1996 Nov; 28(4):306-8. PubMed ID: 9007946
[TBL] [Abstract][Full Text] [Related]
13. Cyclooxygenase-2 expression in human irradiated uveal melanomas.
Ozdal PC; Callejo S; Caissie AL; Edelstein C; Bakalian S; Vianna RN; Burnier MN
Int Ophthalmol; 2008 Feb; 28(1):1-6. PubMed ID: 17603773
[TBL] [Abstract][Full Text] [Related]
14. Apoptosis inhibitor, survivin, in posterior uveal melanoma: comparison among primary tumors, tumors resistant to brachytherapy, tumors with liver metastases, and liver metastases.
Ben Simon GJ; Abulafia A; Pe'er J
Curr Eye Res; 2006 Mar; 31(3):251-7. PubMed ID: 16531282
[TBL] [Abstract][Full Text] [Related]
15. [High-dose 106Ruthenium plaque brachytherapy for posterior uveal melanoma. A clinico-pathologic study].
Heindl LM; Lotter M; Strnad V; Sauer R; Naumann GO; Knorr HL
Ophthalmologe; 2007 Feb; 104(2):149-57. PubMed ID: 17123048
[TBL] [Abstract][Full Text] [Related]
16. Ruthenium-106 plaque brachytherapy for thick posterior uveal melanomas.
Kaiserman N; Kaiserman I; Hendler K; Frenkel S; Pe'er J
Br J Ophthalmol; 2009 Sep; 93(9):1167-71. PubMed ID: 19570767
[TBL] [Abstract][Full Text] [Related]
17. Survival, anatomic, and functional long-term results in choroidal and ciliary body melanoma after ruthenium brachytherapy (15 years' experience with beta-rays).
Rouberol F; Roy P; Kodjikian L; Gérard JP; Jean-Louis B; Grange JD
Am J Ophthalmol; 2004 May; 137(5):893-900. PubMed ID: 15126155
[TBL] [Abstract][Full Text] [Related]
18. Cobalt-60 plaque radiotherapy vs enucleation for posterior uveal melanoma.
Augsburger JJ; Gamel JW; Lauritzen K; Brady LW
Am J Ophthalmol; 1990 May; 109(5):585-92. PubMed ID: 2333923
[TBL] [Abstract][Full Text] [Related]
19. [Preoperative irradiation before enucleation in malignant melanoma of the uvea. Review of the literature and initial personal experiences].
Bornfeld N; Huser U; Sauerwein W; Wessing A; Sack H
Klin Monbl Augenheilkd; 1989 Apr; 194(4):252-60. PubMed ID: 2657203
[TBL] [Abstract][Full Text] [Related]
20. Ruthenium brachytherapy for uveal melanoma, 1979-2003: survival and functional outcomes in the Swedish population.
Bergman L; Nilsson B; Lundell G; Lundell M; Seregard S
Ophthalmology; 2005 May; 112(5):834-40. PubMed ID: 15878063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
